Lifevantage PE Ratio 2010-2025 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of June 30, 2025 is 16.48.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-30 13.08 18.96
2025-03-31 14.53 $0.69 21.06
2024-12-31 17.43 $0.56 31.12
2024-09-30 11.98 $0.32 37.43
2024-06-30 6.34 $0.23 27.56
2024-03-31 5.94 $0.28 21.22
2023-12-31 5.86 $0.23 25.49
2023-09-30 6.27 $0.20 31.34
2023-06-30 3.98 $0.20 19.91
2023-03-31 3.26 $-0.06 0.00
2022-12-31 3.35 $-0.05 0.00
2022-09-30 3.35 $0.04 83.83
2022-06-30 3.86 $0.24 16.09
2022-03-31 4.19 $0.70 5.99
2021-12-31 5.57 $0.73 7.63
2021-09-30 5.96 $0.98 6.09
2021-06-30 6.47 $0.90 7.19
2021-03-31 8.24 $0.81 10.17
2020-12-31 8.21 $0.80 10.26
2020-09-30 10.63 $0.84 12.66
2020-06-30 11.91 $0.79 15.08
2020-03-31 9.07 $0.79 11.49
2019-12-31 13.75 $0.80 17.19
2019-09-30 12.07 $0.56 21.55
2019-06-30 11.43 $0.50 22.87
2019-03-31 12.59 $0.45 27.97
2018-12-31 11.62 $0.45 25.82
2018-09-30 9.68 $0.41 23.61
2018-06-30 5.61 $0.41 13.69
2018-03-31 3.18 $0.21 15.14
2017-12-31 4.19 $0.09 46.59
2017-09-30 3.72 $0.09 41.30
2017-06-30 3.81 $0.11 34.68
2017-03-31 4.73 $0.26 18.19
2016-12-31 7.18 $0.33 21.76
2016-09-30 8.33 $0.42 19.84
2016-06-30 11.98 $0.42 28.52
2016-03-31 8.02 $0.26 30.83
2015-12-31 8.39 $0.26 32.25
2015-09-30 4.99 $0.22 22.70
2015-06-30 3.27 $0.49 6.67
2015-03-31 4.87 $0.63 7.73
2014-12-31 8.02 $0.70 11.45
2014-09-30 7.03 $0.84 8.37
2014-06-30 8.88 $0.70 12.69
2014-03-31 8.08 $0.56 14.43
2013-12-31 10.17 $0.63 16.16
2013-09-30 14.68 $0.42 34.96
2013-06-30 14.31 $0.42 34.08
2013-03-31 14.49 $0.70 20.71
2012-12-31 13.50 $0.14 96.46
2012-09-30 21.15 $0.49 43.17
2012-06-30 17.45 $0.42 41.55
2012-03-31 23.19 $-3.78 0.00
2011-12-31 8.82 $-4.34 0.00
2011-09-30 9.25 $-4.27 0.00
2011-06-30 9.25 $-4.34 0.00
2011-03-31 4.38 $-0.98 0.00
2010-12-31 2.40 $-1.05 0.00
2010-09-30 3.08 $-1.54 0.00
2010-06-30 3.14 $-1.47 0.00
2010-03-31 2.40 $-1.68 0.00
2009-12-31 1.54 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.160B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.804B 21.93
Becton Dickinson (BDX) United States $48.970B 12.13
Cardinal Health (CAH) United States $39.902B 20.90
Straumann Holding AG (SAUHY) Switzerland $20.809B 0.00
West Pharmaceutical Services (WST) United States $15.725B 32.96
Cooper (COO) United States $14.227B 18.33
Align Technology (ALGN) United States $13.665B 27.12
Henry Schein (HSIC) United States $8.918B 15.30
Merit Medical Systems (MMSI) United States $5.526B 26.71
DENTSPLY SIRONA (XRAY) United States $3.175B 9.48
CONMED (CNMD) United States $1.614B 12.08
STAAR Surgical (STAA) United States $0.838B 0.00
Pro-Dex (PDEX) United States $0.146B 16.03